Oxford Vacmedix licences AMR diagnostic to Changzhou Biotech
Oxford Vacmedix licences its novel diagnostic test for Anti Microbial Resistance to Changzhou Biotech for Greater China Oxford, UK – 11th April 2024 Press Release – OVM licences AMR diagnostic to CBI Oxford Vacmedix (OVM), the clinical stage company developing therapeutic cancer vaccines, announced today the grant of a licence for its novel diagnostic test […]
Oxford Vacmedix licences AMR diagnostic to Changzhou Biotech Read More »